Whole-Exome-Sequencing-Based Discovery of Human FADD Deficiency

Citation
Bolze, Alexandre et al., Whole-Exome-Sequencing-Based Discovery of Human FADD Deficiency, American journal of human genetics (Online) AJHG , 87(6), 2010, pp. 873-881
ISSN journal
15376605
Volume
87
Issue
6
Year of publication
2010
Pages
873 - 881
Database
ACNP
SICI code
Abstract
Germline mutations in FASL and FAS impair Fas-dependent apoptosis and cause recessively or dominantly inherited autoimmune lymphoproliferative syndrome (ALPS). Patients with ALPS typically present with no other clinical phenotype. We investigated a large, consanguineous, multiplex kindred in which biological features of ALPS were found in the context of severe bacterial and viral disease, recurrent hepatopathy and encephalopathy, and cardiac malformations. By a combination of genome-wide linkage and whole-exome sequencing, we identified a homozygous missense mutation in FADD, encoding the Fas-associated death domain protein (FADD), in the patients. This FADD mutation decreases steady-state protein levels and impairs Fas-dependent apoptosis in vitro, accounting for biological ALPS phenotypes in vivo. It also impairs Fas-independent signaling pathways. The observed bacterial infections result partly from functional hyposplenism, and viral infections result from impaired interferon immunity. We describe here a complex clinical disorder, its genetic basis, and some of the key mechanisms underlying its pathogenesis. Our findings highlight the key role of FADD in Fas-dependent and Fas.independent signaling pathways in humans.